Carlos H. T. P. da Silva - Search Results

Year	Number of Results
2005	1
2006	2
2007	4
2008	1
2010	1
2011	1
2015	4
2016	1
2017	2
2018	3
2020	3
2022	2
2024	0

1

Parkinson's Disease: A Review from Pathophysiology to Treatment.

Marino BLB, de Souza LR, Sousa KPA, Ferreira JV, Padilha EC, da Silva CHTP, Taft CA, Hage-Melim LIS. Marino BLB, et al. Among authors: da silva chtp. Mini Rev Med Chem. 2020;20(9):754-767. doi: 10.2174/1389557519666191104110908. Mini Rev Med Chem. 2020. PMID: 31686637 Review.

2

Pharmacophore-based virtual screening from phytocannabinoids as antagonist r-CB1.

Correia LC, Ferreira JV, de Lima HB, Silva GM, da Silva CHTP, de Molfetta FA, Hage-Melim LIS. Correia LC, et al. Among authors: da silva chtp. J Mol Model. 2022 Aug 17;28(9):258. doi: 10.1007/s00894-022-05219-3. J Mol Model. 2022. PMID: 35978141

3

Current basis for discovery and development of aryl hydrocarbon receptor antagonists for experimental and therapeutic use in atherosclerosis.

Pernomian L, da Silva CHTP. Pernomian L, et al. Among authors: da silva chtp. Eur J Pharmacol. 2015 Oct 5;764:118-123. doi: 10.1016/j.ejphar.2015.06.058. Epub 2015 Jul 2. Eur J Pharmacol. 2015. PMID: 26142084 Review.

4

Pharmacological significance of the interplay between angiotensin receptors: MAS receptors as putative final mediators of the effects elicited by angiotensin AT1 receptors antagonists.

Pernomian L, Pernomian L, Gomes MS, da Silva CH. Pernomian L, et al. Among authors: da silva ch. Eur J Pharmacol. 2015 Dec 15;769:143-6. doi: 10.1016/j.ejphar.2015.11.009. Epub 2015 Nov 6. Eur J Pharmacol. 2015. PMID: 26548625 Review.

5

Hierarchical Virtual Screening Based on Rocaglamide Derivatives to Discover New Potential Anti-Skin Cancer Agents.

Dos Santos IVF, Borges RS, Silva GM, de Lima LR, Bastos RS, Ramos RS, Silva LB, da Silva CHTP, Dos Santos CBR. Dos Santos IVF, et al. Among authors: da silva chtp. Front Mol Biosci. 2022 Jun 2;9:836572. doi: 10.3389/fmolb.2022.836572. eCollection 2022. Front Mol Biosci. 2022. PMID: 35720115 Free PMC article.

6

Proposition of Potential GSK-3β Inhibitors for the Treatment of Alzheimer's Disease: A Molecular Modeling Study.

Castro LL, Picanço LCS, Silva JV, Souza LR, Sousa KPA, Pinheiro AA, Chaves GA, Teixeira HRC, Silva GM, Taft CA, de P da Silva CHT, da S Hage-Melim LI. Castro LL, et al. Among authors: de p da silva cht. Curr Comput Aided Drug Des. 2020;16(5):541-554. doi: 10.2174/1573409915666191015110734. Curr Comput Aided Drug Des. 2020. PMID: 31749432

7

Identification of Novel Chemical Entities for Adenosine Receptor Type 2A Using Molecular Modeling Approaches.

Santos KLBD, Cruz JN, Silva LB, Ramos RS, Neto MFA, Lobato CC, Ota SSB, Leite FHA, Borges RS, Silva CHTPD, Campos JM, Santos CBR. Santos KLBD, et al. Among authors: silva chtpd. Molecules. 2020 Mar 10;25(5):1245. doi: 10.3390/molecules25051245. Molecules. 2020. PMID: 32164183 Free PMC article.

8

Molecular modeling and statistical analysis in the design of derivatives of human dipeptidyl peptidase IV.

Pereira ALE, Dos Santos GB, Franco MSF, Federico LB, da Silva CHTP, Santos CBR. Pereira ALE, et al. Among authors: da silva chtp. J Biomol Struct Dyn. 2018 Feb;36(2):318-334. doi: 10.1080/07391102.2016.1277163. Epub 2017 Jan 24. J Biomol Struct Dyn. 2018. PMID: 28027711

9

Identification of Novel Protein Kinase Receptor Type 2 Inhibitors Using Pharmacophore and Structure-Based Virtual Screening.

Cruz JV, Neto MFA, Silva LB, da S Ramos R, da S Costa J, Brasil DSB, Lobato CC, da Costa GV, Bittencourt JAHM, da Silva CHTP, Leite FHA, Santos CBR. Cruz JV, et al. Among authors: da silva chtp. Molecules. 2018 Feb 18;23(2):453. doi: 10.3390/molecules23020453. Molecules. 2018. PMID: 29463017 Free PMC article.

10

MAS receptors mediate vasoprotective and atheroprotective effects of candesartan upon the recovery of vascular angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS axis functionality.

Pernomian L, do Prado AF, Gomes MS, Pernomian L, da Silva CHTP, Gerlach RF, de Oliveira AM. Pernomian L, et al. Among authors: da silva chtp. Eur J Pharmacol. 2015 Oct 5;764:173-188. doi: 10.1016/j.ejphar.2015.07.007. Epub 2015 Jul 2. Eur J Pharmacol. 2015. PMID: 26144375

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

22 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year